StockData

Aibotics, Inc. (AIBT) stock

AIBTOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30
$0.00+0.00 (+42.86%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Aibotics gross margin

Gross margin is gross profit as a percentage of revenue.

Aibotics's gross margin for the twelve months ending Dec 31, 2025 was 100.0%. For fiscal 2025 it was 100.0%.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025100.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2025Mar 31, 2025100.0%+95.3
Q3 FY2019Sep 30, 20194.4%–
Q2 FY2019Jun 30, 20194.2%–
Q3 FY2018Sep 30, 20184.6%–
Q2 FY2018Jun 30, 20184.7%–

More Aibotics figures

See a number that looks wrong?